financing

News

TORL rakes in $158m for ADCs, and other bio financings

Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.

R&D

Green shoots and cautious optimism: Insights from BIO-Europe...

With thousands of pharma and biotech dealmakers attending last months’ BIO-Europe Spring, appetite for partnering looked alive and well.

News

e-therapeutics' chief executive Ali Mortazavi

e-therapeutics is latest UK biotech to seek AIM de-listing

e-therapeutics has become the latest UK biotech to say it plans to delist from the Alternative Investment Market (AIM) in another blow to the reputation of the London Stoc

News

Karuna founder Daphne Zohar, now CEO of Seaport Therapeutics

Ex-Karuna team launch Seaport with $100m for psychiatry meds

The team that brought you Karuna – recently sold to Bristol-Myers Squibb for $14 billion – has set up a neuropsychiatry-focused biotech called Seaport Therapeutics.

News

Aardvark said to be planning IPO, plus other bio financings

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emergin

News

Praia emerges with $20m for digital health platform

Healthcare system Providence has spun out a new company, Praia Health, focused on a platform to build and sustain connections between patients and health providers.

TORL rakes in $158m for ADCs, and other bio financings

Green shoots and cautious optimism: Insights from BIO-Europe...

e-therapeutics is latest UK biotech to seek AIM de-listing

Ex-Karuna team launch Seaport with $100m for psychiatry meds

Aardvark said to be planning IPO, plus other bio financings

Praia emerges with $20m for digital health platform

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

financing

Editor's Picks